More Pro Medicus, Ltd. news
Pro Medicus, Ltd.ASX: PME

CEO Interview - 1H21 results

Feb 16, 2021 at 11:43 PM EST · Issued by Pro Medicus, Ltd.

Filed with ASX · Feb 16, 2021 at 11:43 PM EST

On 6ix: 6ix.com/news/ceo-interview-1h21-results

Pro Medicus Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Pro Medicus, Ltd. on 6ix

In the deck

  • Pro Medicus — H1 2021 Earnings Presentation38 slidesFeb 17, 2021

Story so far

  • CEO Interview - Intermountain dealJan 14, 2021
  • CEO Interview Medstar deal and single vendor solutionDec 17, 2020
  • CEO Interview - NYU Langone Health dealSep 11, 2020

Earlier from Pro Medicus

  • Dividend/Distribution - PMEFeb 16, 2021
  • PME signs A$31M - 7 year deal with major US Health SystemFeb 15, 2021
  • PME receives FDA approval for Breast Density AlgorithmFeb 1, 2021
  • CEO Interview - Intermountain dealJan 13, 2021
  • PME signs A$40M - 7 year contract with Intermountain HealthJan 13, 2021

Later from Pro Medicus

  • On market share buy-backMar 31, 2021
  • Pro Medicus: PME Signs 8-year Contract with The University of Vermont Health Network Inc.May 12, 2021
  • PME signs A$14M, 8 year deal with University of VermontMay 13, 2021
  • Pro Medicus: PME Signs Research Collaboration Agreement with Mayo ClinicJun 2, 2021
  • Interview with CEO - Full year resultsAug 17, 2021
All Pro Medicus news releases↗

Follow Pro Medicus into a list and get an email when it puts out news.

Follow Pro Medicus
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer